We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Matt
Dickinson
matthew.dickinson@nhs.net
Dr
Kat
Papadopoulou
aikaterini.papadopoulou@nhs.net
Elective surgery for intra-abdominal cancer
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
During surgery the body goes through physiological changes that put it under stress and require the presence of adequate blood flow in order to avoid the development of complications. Previous studies have shown that if the blood flow to an arm is briefly reduced (like when a blood pressure cuff is inflated), then the stress to the body is less and the complications are reduced. This technique is called remote ischaemic preconditioning or RIPC. These studies have been done mainly in cardiac surgery. There are only a few studies using RIPC in cancer surgery.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35407378/ (added 18/07/2022)
You can take part if:
You may not be able to take part if:
1. Patients unable to give consent2. Day surgery3. Emergency surgery4. Total intravenous anaesthesia5. Pregnancy6. Recent (< 1 month) or ongoing acute myocardial infarction7. Unstable or ongoing angina8. Peripheral vascular disease9. History of vascular intervention in the limb to be used for RIPC10. Thromboembolic disease11. Significant coagulopathy or bleeding diathesis12. Sickle cell disease13. Neuromuscular diseases 14. Use of sulfonylureas or nicorandil
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by Royal Surrey County Hospital and funded by Inspire Foundation.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS: 38780
You can print or share the study information with your GP/healthcare provider or contact the research team directly.